Brief: Nanexa Comments On News About License On Long-Acting Technology Platform
05/11/2024 07:09
Nov 5 (Reuters) - Nanexa AB NANEXA.ST :
* COMMENTS ON NEWS ABOUT THE LICENSE ON A LONG-ACTING
TECHNOLOGY
PLATFORM PUBLISHED THIS MONDAY
* IT IS CLEAR THAT WE HAVE SEVERAL COMPANIES INTERESTED IN
PHARMASHELL TECHNOLOGY FOR USE TO DEVELOP LONG-ACTING GLP-1
PRODUCTS AND OTHERS
Source text: ID:nMFN8snFn
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))